DLF invites Private Equity players to its middle income homes business

Published in November 19th, 2007

DLF Ltd has announced that the Company has attracted participation of private equity real estate funds in its township projects by diluting 49% equity stake at a premium, in seven residential projects to a Merrill Lynch & Co entity for a consideration of Rs 1481 crore.
The mid-income housing projects, located in Chennai, Bangalore, Kochi and [...]

Suzlon Energy Australia bags 200MW Order

Published in November 19th, 2007

Posted by webmaster in Market News, US Markets, World Economy

1 Comment

Suzlon Energy Ltd has announced that Suzlon Energy Australia Pty Ltd, Australia; the step-down wholly owned subsidiary of the Company has signed two major new orders in Australia. The contracts totaling over 200 MW of capacity were signed with Sydney’s Renewable Power Ventures (RPV) and utility major AGL Energy.

Gitanjali Gems acquires Rogers Ltd Inc USA

Published in November 19th, 2007

Posted by webmaster in Market News, US Markets

No Comments

Gitanjali Gems Ltd has announced that the Company has acquired Rogers Ltd. Inc., a retail jewelry chain in United States.
The Company has acquired 100% stake in this specialty retailer, which operates 46 stores in US with current revenues equivalent to US$ 80 Million. Rogers Ltd. Inc. is headquartered in Middletown, Ohio and operates under brand [...]

L&T led JV Bags Rs 275 Crore Tunneling Order for Airport Line of DMRC

Published in November 19th, 2007

Posted by webmaster in Market News

No Comments

Larsen & Toubro Ltd (L&T) has announced that the Company in association with Shanghai Urban Construction (Group) Corporation has secured a Design & Build contract valued at Rs 275 crore from Delhi Metro Railway Corporation Ltd (DMRC). The contract is for the construction of 2.4 km of Underground Twin Tunnel starting from the IGI Airport [...]

Celgene to buy Pharmion for $2.9Billion

Published in November 19th, 2007

Posted by webmaster in Market News, US Markets

No Comments

Celgene Corp. has agreed to acquire Pharmion Corp. for $72 a share in a cash-and-stock deal worth $2.9 billion. Celgene said this deal will give boost to its strategy in the hematology and oncology field and brings together three medical therapies — Revlimid, Thalomid and Vidaza — that are expected to accelerate revenue and earnings [...]